An open-label phase 2a study in subjects with N-cadherin positive, advanced or recurrent solid tumors to investigate the safety and efficacy of ADH-1 administered intravenously as a single agent (Adherex protocol number AHX-01-201)

Trial Profile

An open-label phase 2a study in subjects with N-cadherin positive, advanced or recurrent solid tumors to investigate the safety and efficacy of ADH-1 administered intravenously as a single agent (Adherex protocol number AHX-01-201)

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2007

At a glance

  • Drugs ADH 1 (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Aug 2007 Status change from in progress to completed.
    • 18 Jan 2007 Status changed from recruiting to in progress.
    • 31 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top